J Korean Med Sci.  2014 Jul;29(7):885-885. 10.3346/jkms.2014.29.7.885.

Increasing Burden of Alzheimer's Disease by Aging

• Han SH

• KMID: 1789945
• DOI: http://doi.org/10.3346/jkms.2014.29.7.885

Abstract

No abstract available.

MeSH Terms

*Aging
Alzheimer Disease/drug therapy/economics/*pathology
Cost of Illness
Excitatory Amino Acid Agonists/therapeutic use
Health Behavior
Humans
N-Methylaspartate/therapeutic use
Risk Factors
Excitatory Amino Acid Agonists
N-Methylaspartate

Reference

1. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med. 2010; 362:329–344.

2. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011; 10:819–828.

3. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005; 366:2112–2117.

4. Mohamed S, Rosenheck R, Lyketsos CG, Schneider LS. Caregiver burden in Alzheimer disease: cross-sectional and longitudinal patient correlates. Am J Geriatr Psychiatry. 2010; 18:917–927.

5. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998; 88:1337–1342.